Specialty Pharmacy Continuum

Specialty Pharmacy Continuum (SPC) aims to deliver precise, pertinent, and current clinical and business insights to specialty pharmacists, home infusion specialists, managed care organizations, and other important players in the specialty pharmacy sector.

National, Trade/B2B

English

Magazine

Outlet metrics

Domain Authority

Ranking

Global

#4691766

United States

#1747652

Articles

Sepsis and IG: Tips for Early Identification at Home

2 weeks ago | specialtypharmacycontinuum.com | Heidi Splete

Sepsis remains a concern for people on immune globulin therapy, especially those receiving infusions at home, but identification of risk factors and patient education can prevent or catch sepsis early, said Ying-Tang Casapao, PharmD, MBA, BCPPS, in a presentation at the IgNS 2024 National Conference, in Washington, D.C. Early on, sepsis presents as an infection plus at least two of three symptoms: fever, mental decline or feeling extremely ill, said Dr. Casapao, a clinical pharmacist educator...
Basics and Benefits of Biosimilars: A Rheumatologist’s Take

2 weeks ago | specialtypharmacycontinuum.com | Heidi Splete

Biosimilars can improve patient access and reduce healthcare costs, but understanding basic concepts about this growing drug class can help optimize those benefits, according to Colin C.
Trump Prescription Drug Order Puts Spotlight on Price Tensions for Biosimilars

3 weeks ago | specialtypharmacycontinuum.com | Fran Kritz

By Fran Kritz On April 15, President Trump issued an executive order aimed at lowering prescription drug prices that requires the FDA commissioner to issue a report within 180 days “providing administrative and legislative recommendations to accelerate approval of generics, biosimilars, combination products, and second-in-class brand name medications.” In a fact sheet the White House summarized efforts to increase the availability of generics and biosimilars through measures including:...
Ensitrelvir PEP Continues to Prevent SARS-CoV-2 Infection

1 month ago | specialtypharmacycontinuum.com | Marie Rosenthal

Originally published by our sister publication Infectious Disease Special EditionBy Marie Rosenthal, MSIf given within 72 hours after clinical onset of COVID-19 in a household, oral ensitrelvir was effective in protecting household contacts from SARS-CoV-2 infection, according to a presentation at ESCMID Global 2025, in Vienna (abstract 03159). Protection was consistently seen in all at-risk groups studied, including older household contacts, according to Frederick G. Hayden, MD, the Stuart S.
Overcoming Biosimilar Utilization Barriers

1 month ago | specialtypharmacycontinuum.com | Gina Shaw

The successful implementation of an infliximab biosimilar at Boston Medical Center (BMC) was one of several lessons for overcoming operational challenges and stakeholder barriers to biosimilar adoption presented during a session at the ASHP Midyear 2024 Clinical Meeting & Exhibition, in New Orleans.
ASHP Meeting Puts Spotlight On Fixes for Pharmacy Burnout

1 month ago | specialtypharmacycontinuum.com | Kate Baggaley

Several campaigns aimed at addressing burnout among healthcare workers and strategies for promoting pharmacist well-being at an organizational level were highlighted at the ASHP Midyear 2024 Clinical Meeting & Exhibition, in New Orleans. Speakers emphasized that the onus should not be on individual pharmacists to make themselves more resilient.
CROI Rebecca Denison HIV Quality of Life

1 month ago | specialtypharmacycontinuum.com | Marie Rosenthal

Originally published by our sister publication Infectious Disease Special EditionBy Marie Rosenthal, MSA long-term HIV survivor, Rebecca Denison said healthcare professionals should make sure that people living with HIV understand they can live normal lives that include meaningful work, having families and loving relationships. But such a life does not come without challenges.
Closing the Door on Barrett’s: The Critical Role of Reflux Control in EET Outcomes

1 month ago | specialtypharmacycontinuum.com | Chase Doyle |Sarah Tilyou

Originally published by our sister publication Gastroenterology & Endoscopy NewsBy Chase Doyle and Sarah TilyouDENVER—Despite two decades of progress in ablation techniques, the incidence of esophageal cancer has remained largely unchanged, prompting some experts to reevaluate their approach to management of Barrett’s esophagus. In a presentation at the 2024 annual meeting of the American Foregut Society.
Although Safe, Tecovirimat Proves Ineffective for Treating Clade II Mpox

2 months ago | specialtypharmacycontinuum.com | Marie Rosenthal

Originally published by our sister publication Infectious Disease Special Edition By Marie Rosenthal, MS More data from the STOMP (Study of Tecovirimat for Mpox) trial presented at CROI 2025, held in San Francisco, confirm that tecovirimat does not reduce the time to clinical resolution of clade II mpox lesions or improve pain among adults, according to Timothy Wilkin, MD, MPH, a professor of medicine and the chief of the Division of Infectious Diseases and Global Public Health at the...
Ensitrelvir Reduced the Risk for COVID-19 by 67%

2 months ago | specialtypharmacycontinuum.com | Marie Rosenthal

Originally published by our sister publication Infectious Disease Special EditionBy Marie Rosenthal, MSEnsitrelvir, an antiviral being developed to prevent COVID-19, reduced the risk of developing the infection by 67% in uninfected people after exposure to SARS-CoV-2 compared with placebo at day 10, according to results presented at CROI 2025, held in San Francisco (abstract 200).